Use of riociguat as front-line therapy in a patient with high-risk pulmonary arterial hypertension and right ventricular failure.

1 September 2024 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension (2) Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo

Unidad Medica de Alta Especialidad Hospital de Cardiologia No. 34 IMSS, Monterrey (Mexico)

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET

ESC 365 is supported by

ESC 365 is supported by